EPAS1 and sarcoma: To determine if ANO1 inhibition diminished HIF-2α deficient sarcoma growth in vivo, Ano1 targeted shRNAs were introduced into KP and KPH2-derived UPS cells (Supplementary Fig. 4d,e) to generate allografts.